Zeranol stimulates proliferation and aromatase activation in human breast preadipocytes

  • Authors:
    • Saiyi Zhong
    • Shouchun Liu
    • Suhua Chen
    • Huajuan Lin
    • Weimin Wang
    • Xiaoming Qin
  • View Affiliations

  • Published online on: May 18, 2016     https://doi.org/10.3892/mmr.2016.5293
  • Pages: 1014-1018
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Aromatase is a crucial enzyme for the biosynthesis of estrogens and is involved in the process of breast carcinogenesis. Concerns have been raised regarding the effects of environmental estrogens as potential regulators of aromatase expression in human breast cells. Zeranol is a non‑steroidal agent with potent estrogenic activity, which is widely used as a growth promoter for cattle in certain countries. The present study hypothesized that aromatase expression and activity may be elevated by low dose zeranol exposure, providing a source of estrogens that may stimulate cell proliferation. In the present study, primary cultured human breast preadipocytes were used as an in vitro model. The effects of zeranol on cell proliferation were measured using the MTS assay, aromatase expression levels were determined by immunocytochemical staining and reverse transcription‑polymerase chain reaction, and aromatase enzyme activity and estrogen production were analyzed using corresponding assay kits. The results demonstrated that low dose zeranol (2‑50 nM) was able to significantly promote cell proliferation, aromatase mRNA expression, aromatase activity and estrogen production in primary cultured human breast preadipocytes, thus suggesting that zeranol may act as an aromatase activator. The findings of the present study suggest that zeranol promotes breast cancer cell growth by stimulating aromatase activation and increasing estrogen biosynthesis in adipose tissue.

References

1 

DeSantis C, Ma J, Bryan L and Jemal A: Breast cancer statistics, 2013. CA Cancer J Clin. 64:52–62. 2014. View Article : Google Scholar

2 

Yager JD and Davidson NE: Estrogen carcinogenesis in breast cancer. N Engl J Med. 354:270–282. 2006. View Article : Google Scholar : PubMed/NCBI

3 

Ciocca DR and Fanelli MA: Estrogen receptors and cell proliferation in breast cancer. Trends Endocrinol Metab. 8:313–321. 1997. View Article : Google Scholar

4 

Boon WC, Chow JD and Simpson ER: The multiple roles of estrogens and the enzyme aromatase. Prog Brain Res. 181:209–232. 2010. View Article : Google Scholar : PubMed/NCBI

5 

Liang N, Xu Y, Yin Y, Yao G, Tian H, Wang G, Lian J, Wang Y and Sun F: Steroidogenic factor-1 is required for TGF-beta3-mediated 17beta-estradiol synthesis in mouse ovarian granulosa cells. Endocrinology. 152:3213–3225. 2011. View Article : Google Scholar : PubMed/NCBI

6 

Simpson ER, Michael MD, Agarwal VR, Hinshelwood MM, Bulun SE and Zhao Y: Cytochromes P450 11: Expression of the CYP19 (aromatase) gene: An unusual case of alternative promoter usage. FASEB J. 11:29–36. 1997.PubMed/NCBI

7 

Kamat A, Hinshelwood MM, Murry BA and Mendelson CR: Mechanisms in tissue-specific regulation of estrogen biosynthesis in humans. Trends Endocrin Metab. 13:122–128. 2002. View Article : Google Scholar

8 

Campbell DR and Kurzer MS: Flavonoid inhibition of aromatase enzyme activity in human preadipocytes. J Steroid Biochem Mol Biol. 46:381–388. 1993. View Article : Google Scholar : PubMed/NCBI

9 

Bulun SE, Lin Z, Imir G, Amin S, Demura M, Yilmaz B, Martin R, Utsunomiya H, Thung S, Gurates B, et al: Regulation of aromatase expression in estrogen-responsive breast and uterine disease: From bench to treatment. Pharmacol Rev. 57:359–383. 2005. View Article : Google Scholar : PubMed/NCBI

10 

Lorincz AM and Sukumar S: Molecular links between obesity and breast cancer. Endocr Relat Cancer. 13:279–292. 2006. View Article : Google Scholar : PubMed/NCBI

11 

Dirat B, Bochet L, Dabek M, Daviaud D, Dauvillier S, Majed B, Wang YY, Meulle A, Salles B, Le Gonidec S, et al: Cancer-associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion. Cancer Res. 71:2455–2465. 2011. View Article : Google Scholar : PubMed/NCBI

12 

Arase S, Ishii K, Igarashi K, Aisaki K, Yoshio Y, Matsushima A, Shimohigashi Y, Arima K, Kanno J and Sugimura Y: Endocrine disrupter bisphenol A increases in situ estrogen production in the mouse urogenital sinus. Biolo Reprod. 84:734–742. 2011. View Article : Google Scholar

13 

Manna PR, Dyson MT and Stocco DM: Regulation of the steroidogenic acute regulatory protein gene expression: Present and future perspectives. Mol Hum Reprod. 15:321–333. 2009. View Article : Google Scholar : PubMed/NCBI

14 

Zhong S, Ye W, Lin SH, Liu JY, Leong J, Ma C and Lin YC: Zeranol induces cell proliferation and protein disulfide isomerase expression in mammary gland of ACI rat. Anticancer Res. 31:1659–1665. 2011.PubMed/NCBI

15 

Zhong S, Ye WP, Feng E, Lin SH, Liu JY, Leong J, Ma C and Lin YC: Serum derived from zeranol-implanted ACI rats promotes the growth of human breast cancer cells in vitro. Anticancer Res. 31:481–486. 2011.PubMed/NCBI

16 

Updike MS, Sawdy JC, Wang LS, Liu S, Huang YW, Ye W, Farrar WB, Lin YC and Wick M: Primary cultured human breast epithelial cells up-regulate protein disulfide isomerase in response to zeranol. Anticancer Res. 27:407–410. 2007.PubMed/NCBI

17 

Liu S and Lin YC: Transformation of MCF-10A human breast epithelial cells by zeranol and estradiol-17beta. Breast J. 10:514–521. 2004. View Article : Google Scholar : PubMed/NCBI

18 

Ye W, Xu P, Threlfall WR, Jen R, Li H, Lin SH, Kuo CT and Lin YC: Zeranol enhances the proliferation of preadipocytes in beef heifers. Anticancer Res. 29:5045–5052. 2009.

19 

Zhong S, Ye W, Xu PP, Feng E, Li H, Lin SH, Liu JY, Ma C and Lin YC: Aromatase expression in leptin-pretreated human breast preadipocytes is enhanced by zeranol and suppressed by (−)-gossypol. Anticancer Res. 30:5077–5084. 2010.PubMed/NCBI

20 

Lephart ED and Simpson ER: Assay of aromatase activity. Methods Enzymol. 206:477–483. 1991. View Article : Google Scholar : PubMed/NCBI

21 

Tennant JR: Evaluation of the trypan blue technique for determination of cell viability. Transplantation. 2:685–694. 1964. View Article : Google Scholar : PubMed/NCBI

22 

Russo J and Russo IH: The role of estrogen in the initiation of breast cancer. J Steroid Biochem Mol Biol. 102:89–96. 2006. View Article : Google Scholar : PubMed/NCBI

23 

Smith IE and Dowsett M: Aromatase inhibitors in breast cancer. New Engl J Med. 348:2431–2442. 2003. View Article : Google Scholar : PubMed/NCBI

24 

Utsumi T, Harada N, Maruta M and Takagi Y: Presence of alternatively spliced transcripts of aromatase gene in human breast cancer. J Clin Endocrinol Metab. 81:2344–2349. 1996.PubMed/NCBI

25 

Brodie A, Lu Q and Nakamura J: Aromatase in the normal breast and breast cancer. J Steroid Biochem Mol Biol. 61:281–286. 1997. View Article : Google Scholar : PubMed/NCBI

26 

Blankenstein MA, van de Ven J, Maitimu-Smeele I, Donker GH, de Jong PC, Daroszewski J, Szymczak J, Milewicz A and Thijssen JH: Intratumoural levels of estrogens in breast cancer. J Steroid Biochem Mol Biol. 69:293–297. 1999. View Article : Google Scholar : PubMed/NCBI

27 

Sanderson JT, Seinen W, Giesy JP and van den Berg M: 2-Chloro-s-triazine herbicides induce aromatase (CYP19) activity in H295R human adrenocortical carcinoma cells: A novel mechanism for estrogenicity? Toxicol Sci. 54:121–127. 2000. View Article : Google Scholar : PubMed/NCBI

28 

Morinaga H, Yanase T, Nomura M, Okabe T, Goto K, Harada N and Nawata H: A benzimidazole fungicide, benomyl, and its metabolite, carbendazim, induce aromatase activity in a human ovarian granulose-like tumor cell line (KGN). Endocrinology. 145:1860–1869. 2004. View Article : Google Scholar

29 

Thibaut R and Porte C: Effects of endocrine disrupters on sex steroid synthesis and metabolism pathways in fish. J Steroid Biochem Mol Biol. 92:485–494. 2004. View Article : Google Scholar

30 

Xu P, Ye W, Li H, Lin SH, Kuo CT, Feng E and Lin YC: Zeranol enhances leptin-induced proliferation in primary cultured human breast cancer epithelial cells. Mol Med Rep. 3:795–800. 2010.

31 

Takemura H, Shim JY, Sayama K, Tsubura A, Zhu BT and Shimoi K: Characterization of the estrogenic activities of zearalenone and zeranol in vivo and in vitro. J Steroid Biochem Mol Biol. 103:170–177. 2007. View Article : Google Scholar

Related Articles

Journal Cover

July 2016
Volume 14 Issue 1

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Zhong, S., Liu, S., Chen, S., Lin, H., Wang, W., & Qin, X. (2016). Zeranol stimulates proliferation and aromatase activation in human breast preadipocytes. Molecular Medicine Reports, 14, 1014-1018. https://doi.org/10.3892/mmr.2016.5293
MLA
Zhong, S., Liu, S., Chen, S., Lin, H., Wang, W., Qin, X."Zeranol stimulates proliferation and aromatase activation in human breast preadipocytes". Molecular Medicine Reports 14.1 (2016): 1014-1018.
Chicago
Zhong, S., Liu, S., Chen, S., Lin, H., Wang, W., Qin, X."Zeranol stimulates proliferation and aromatase activation in human breast preadipocytes". Molecular Medicine Reports 14, no. 1 (2016): 1014-1018. https://doi.org/10.3892/mmr.2016.5293